Mesenchymal Stem Cells Market Size, Share & Trends Analysis Report by Product & Services, Workflow Type, Type, Source Of Isolation, Indication, Application, Region, and Segment Forecasts, 2024-2030

The global mesenchymal stem cells (MSC) market size is expected to reach USD 7.27 billion by 2030, expanding at a CAGR of 12.92% from 2024 to 2030. An exponential increase in Mesenchymal Stem Cell (MSC) based research and its implications in the field of regenerative medicine is anticipated to fuel the industry expansion. Moreover, the constantly evolving landscape of cell therapies is also anticipated to propel investments in the mesenchymal stem cells market space; large-scale operational firms are targeting small or emerging players with an operating strategy of acquisition to bolster their market presence.

The strong pipeline of mesenchymal stem cell-based products coupled with emerging applications of mesenchymal stem cells is anticipated to accelerate the industry growth. For instance, in 2022, the U.S.FDA has approved around 19 stem cell therapies for range of life-threatening disorders. Some of these therapies include, BREYANZI of BMS, ALLOCORD, KYMIRAH of Novartis etc. Moreover, a substantial number of companies are exploring the potential of MSCs as therapeutic regime for the management of inflammatory conditions, in turn, boosting market growth.

For instance, on January 2022, the Century Therapeutics and Bristol Myers Squibb entered a collaboration to expand IPSC-derives allogenic cell therapies. In addition, Takeda/TiGenix phase 3 clinical trial incorporated mesenchymal stem cells for complex perianal fistulas in Crohn's Disease. This was the most successful late-stage clinical trial as of September 2020. In addition, in August 2022 AGC Biologics partnered with human mesenchymal stem cell supplier, RoosterBio Inc. to deliver clinically proven advanced therapies for life-threatening conditions. These factors are projected to bolster the usage of stem cell products offered by key entities, thereby intensifying the market competition.

Market players are focused on the expansion of their offerings through extensive R&D and the formation of alliances and partnerships with other major players to sustain their market position. Owing to the recent pandemic of COVID-19, several research and academic research institutes are making focused efforts to develop a treatment regime by using mesenchymal stem cells.

Mesenchymal Stem Cells Market Report Highlights

The products segment dominated the segment and accounted for the largest revenue share of 78.89% in 2023. Among the products, the cells and cell lines segment has emerged as a key contributor to the segment’s revenue
Based on workflow type, the culture and cryopreservation segment dominated the industry with revenue share of 44.55% in 2023. The segment growth is attributed to the high demand for cryopreservation services and enhancement of healthcare infrastructure in developing economies
The allogenic MSCs segment accounted for the higher revenue share of 56.60% in 2023. This is attributed to the high safety profile of allogeneic mesenchymal stem cells in clinical applications
The bone marrow segment dominated the market and accounted for the largest revenue share of 24.56% in 2023. Bone marrow is a major source of isolation for mesenchymal cells
The disease modelling application segment dominated the application and accounted for the largest revenue share of 35.23% in 2023. The use of cellular disease models with patient specific MSCs provides an ideal tool for pathological research
North America dominated the market and accounted for the largest revenue share of 45.11% in 2023. The higher revenue share of the region is accounted to supportive government legislation and rising application of cell therapies in chronic disorders

Chapter 1. Mesenchymal Stem Cells Market: Methodology and Scope

1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, by Company Market Share
1.4.2. Regional Analysis

Chapter 2. Mesenchymal Stem Cells Market: Executive Summary

2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Mesenchymal Stem Cells Market: Variables, Trends, & Scope

3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding Pipeline and Clinical Studies of Mesenchymal Stem Cell Based Products
3.2.1.2. Emerging Applications of MSCs
3.2.1.3. Rising Market Competition Among Key Players
3.2.2. Market Restraint Analysis
3.2.2.1. Lack of Standardized & Regulated Delivery of Stem Cell Therapy
3.2.2.2. Ethical & Safety Concerns Controversies Associated with Human Msc Therapy
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis

Chapter 4. Product & Services Business Analysis

4.1. Product & Services Segment Dashboard
4.2. Mesenchymal Stem Cells Market Product & Services Movement Analysis
4.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
4.4. Products
4.4.1. Products Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.2. Cell & Cell Lines
4.4.2.1. Cell & Cell Lines Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.3. Kits, Media, & Reagents
4.4.3.1. Kits, Media, & Reagents Market Estimates and Forecasts, 2018-2030 (USD Million)
4.4.4. Others
4.4.4.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Services
4.5.1. Services Market Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 5. Workflow Business Analysis

5.1. Workflow Segment Dashboard
5.2. Mesenchymal Stem Cells Market Workflow Movement Analysis
5.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
5.4. Cell Sourcing & Isolation
5.4.1. Cell Sourcing & Isolation Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Culture & Cryopreservation
5.5.1. Culture & Cryopreservation Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Differentiation
5.6.1. Differentiation Market Estimates and Forecasts, 2018-2030 (USD Million)
5.7. Characterization
5.7.1. Characterization Market Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 6. Type Business Analysis

6.1. Type Segment Dashboard
6.2. Mesenchymal Stem Cells Market Type Movement Analysis
6.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
6.4. Autologous
6.4.1. Autologous Market Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Allogeneic
6.5.1. Allogeneic Market Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 7. Source of Isolation Business Analysis

7.1. Source of Isolation Segment Dashboard
7.2. Mesenchymal Stem Cells Market Source of Isolation Movement Analysis
7.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Source of Isolation, 2018 to 2030 (USD Million)
7.4. Bone Marrow
7.4.1. Bone Marrow Market Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Cord Blood
7.5.1. Cord Blood Market Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Peripheral Blood
7.6.1. Peripheral Blood Market Estimates and Forecasts, 2018-2030 (USD Million)
7.7. Fallopian Tube
7.7.1. Fallopian Tube Market Estimates and Forecasts, 2018-2030 (USD Million)
7.8. Fetal Liver
7.8.1. Fetal Liver Market Estimates and Forecasts, 2018-2030 (USD Million)
7.9. Lung
7.9.1. Lung Market Estimates and Forecasts, 2018-2030 (USD Million)
7.10. Adipose Tissues
7.10.1. Adipose Tissues Market Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 8. Indication Business Analysis

8.1. Indication Segment Dashboard
8.2. Mesenchymal Stem Cells Market Indication Movement Analysis
8.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
8.4. Bone & Cartilage Repair
8.4.1. Bone & Cartilage Repair Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Cardiovascular Disease
8.5.1. Cardiovascular Disease Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Inflammatory & Immunological Diseases
8.6.1. Inflammatory & Immunological Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
8.7. Liver Diseases
8.7.1. Liver Diseases Market Estimates and Forecasts, 2018-2030 (USD Million)
8.8. Cancer
8.8.1. Cancer Market Estimates and Forecasts, 2018-2030 (USD Million)
8.9. GvHD
8.9.1. GvHD Market Estimates and Forecasts, 2018-2030 (USD Million)
8.10. Others
8.10.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 9. Application Business Analysis

9.1. Application Segment Dashboard
9.2. Mesenchymal Stem Cells Market Application Movement Analysis
9.3. Mesenchymal Stem Cells Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
9.4. Disease Modeling
9.4.1. Disease Modeling Market Estimates and Forecasts, 2018-2030 (USD Million)
9.5. Drug Development & Discovery
9.5.1. Drug Development & Discovery Market Estimates and Forecasts, 2018-2030 (USD Million)
9.6. Stem Cell Banking
9.6.1. Stem Cell Banking Market Estimates and Forecasts, 2018-2030 (USD Million)
9.7. Tissue Engineering
9.7.1. Tissue Engineering Market Estimates and Forecasts, 2018-2030 (USD Million)
9.8. Toxicology Studies
9.8.1. Toxicology Studies Market Estimates and Forecasts, 2018-2030 (USD Million)
9.9. Others
9.9.1. Others Market Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 10. Regional Business Analysis by Product & Services, Workflow Type, Type, Source of Isolation, Indication, and Application

10.1. Regional Dashboard
10.2. Market Size & Forecast and Trend Analysis, 2023 & 2030
10.3. North America
10.3.1. North America Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.3.2. U.S.
10.3.2.1. Key Country Dynamics
10.3.2.2. Competitive Scenario
10.3.2.3. Target Disease Prevalence
10.3.2.4. U.S. Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.3.3. Canada
10.3.3.1. Key Country Dynamics
10.3.3.2. Competitive Scenario
10.3.3.3. Target Disease Prevalence
10.3.3.4. Canada Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4. Europe
10.4.1. Europe Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4.2. UK
10.4.2.1. Key Country Dynamics
10.4.2.2. Competitive Scenario
10.4.2.3. Target Disease Prevalence
10.4.2.4. UK Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4.3. Germany
10.4.3.1. Key Country Dynamics
10.4.3.2. Competitive Scenario
10.4.3.3. Target Disease Prevalence
10.4.3.4. Germany Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4.4. France
10.4.4.1. Key Country Dynamics
10.4.4.2. Competitive Scenario
10.4.4.3. Target Disease Prevalence
10.4.4.4. France Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4.5. Italy
10.4.5.1. Key Country Dynamics
10.4.5.2. Competitive Scenario
10.4.5.3. Target Disease Prevalence
10.4.5.4. Italy Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4.6. Spain
10.4.6.1. Key Country Dynamics
10.4.6.2. Competitive Scenario
10.4.6.3. Target Disease Prevalence
10.4.6.4. Spain Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4.7. Denmark
10.4.7.1. Key Country Dynamics
10.4.7.2. Competitive Scenario
10.4.7.3. Target Disease Prevalence
10.4.7.4. Denmark Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4.8. Sweden
10.4.8.1. Key Country Dynamics
10.4.8.2. Competitive Scenario
10.4.8.3. Target Disease Prevalence
10.4.8.4. Sweden Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.4.9. Norway
10.4.9.1. Key Country Dynamics
10.4.9.2. Competitive Scenario
10.4.9.3. Target Disease Prevalence
10.4.9.4. Norway Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.5. Asia-Pacific
10.5.1. Asia-Pacific Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.5.2. Japan
10.5.2.1. Key Country Dynamics
10.5.2.2. Competitive Scenario
10.5.2.3. Target Disease Prevalence
10.5.2.4. Japan Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.5.3. China
10.5.3.1. Key Country Dynamics
10.5.3.2. Competitive Scenario
10.5.3.3. Target Disease Prevalence
10.5.3.4. China Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.5.4. India
10.5.4.1. Key Country Dynamics
10.5.4.2. Competitive Scenario
10.5.4.3. Target Disease Prevalence
10.5.4.4. India Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.5.5. Australia
10.5.5.1. Key Country Dynamics
10.5.5.2. Competitive Scenario
10.5.5.3. Target Disease Prevalence
10.5.5.4. Australia Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.5.6. Thailand
10.5.6.1. Key Country Dynamics
10.5.6.2. Competitive Scenario
10.5.6.3. Target Disease Prevalence
10.5.6.4. Thailand Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.5.7. South Korea
10.5.7.1. Key Country Dynamics
10.5.7.2. Competitive Scenario
10.5.7.3. Target Disease Prevalence
10.5.7.4. South Korea Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.6. Latin America
10.6.1. Latin America Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.6.2. Brazil
10.6.2.1. Key Country Dynamics
10.6.2.2. Competitive Scenario
10.6.2.3. Target Disease Prevalence
10.6.2.4. Brazil Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.6.3. Mexico
10.6.3.1. Key Country Dynamics
10.6.3.2. Competitive Scenario
10.6.3.3. Target Disease Prevalence
10.6.3.4. Mexico Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.6.4. Argentina
10.6.4.1. Key Country Dynamics
10.6.4.2. Competitive Scenario
10.6.4.3. Target Disease Prevalence
10.6.4.4. Argentina Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.7. MEA
10.7.1. MEA Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.7.2. South Africa
10.7.2.1. Key Country Dynamics
10.7.2.2. Competitive Scenario
10.7.2.3. Target Disease Prevalence
10.7.2.4. South Africa Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.7.3. Saudi Arabia
10.7.3.1. Key Country Dynamics
10.7.3.2. Competitive Scenario
10.7.3.3. Target Disease Prevalence
10.7.3.4. Saudi Arabia Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.7.4. UAE
10.7.4.1. Key Country Dynamics
10.7.4.2. Competitive Scenario
10.7.4.3. Target Disease Prevalence
10.7.4.4. UAE Mesenchymal Stem Cells Market, 2018-2030 (USD Million)
10.7.5. Kuwait
10.7.5.1. Key Country Dynamics
10.7.5.2. Competitive Scenario
10.7.5.3. Target Disease Prevalence
10.7.5.4. Kuwait Mesenchymal Stem Cells Market, 2018-2030 (USD Million)

Chapter 11. Competitive Landscape

11.1. Company Categorization
11.2. Strategy Mapping
11.3. Company Market Position Analysis, 2023
11.4. Company Profiles/Listing
11.4.1. Thermo Fisher Scientific, Inc.
11.4.1.1. Overview
11.4.1.2. Financial Performance
11.4.1.3. Product Benchmarking
11.4.1.4. Strategic Initiatives
11.4.2. Cell Applications, Inc.
11.4.2.1. Overview
11.4.2.2. Product Benchmarking
11.4.2.3. Strategic Initiatives
11.4.3. Cyagen Biosciences
11.4.3.1. Overview
11.4.3.2. Product Benchmarking
11.4.3.3. Strategic Initiatives
11.4.4. Axol Bioscience Ltd.
11.4.4.1. Overview
11.4.4.2. Product Benchmarking
11.4.4.3. Strategic Initiatives
11.4.5. STEMCELL Technologies
11.4.5.1. Overview
11.4.5.2. Product Benchmarking
11.4.5.3. Strategic Initiatives
11.4.6. Celprogen Inc.
11.4.6.1. Overview
11.4.6.2. Product Benchmarking
11.4.6.3. Strategic Initiatives
11.4.7. Cellcolabs
11.4.7.1. Overview
11.4.7.2. Product Benchmarking
11.4.7.3. Strategic Initiatives
11.4.8. Stemedica Cell Technologies, Inc.
11.4.8.1. Overview
11.4.8.2. Product Benchmarking
11.4.8.3. Strategic Initiatives
11.4.9. Merck KGaA
11.4.9.1. Overview
11.4.9.2. Financial Performance
11.4.9.3. Product Benchmarking
11.4.9.4. Strategic Initiatives
11.4.10. Lonza
11.4.10.1. Overview
11.4.10.2. Financial Performance
11.4.10.3. Product Benchmarking
11.4.10.4. Strategic Initiatives
11.4.11. PromoCell GmbH
11.4.11.1. Overview
11.4.11.2. Product Benchmarking
11.4.11.3. Strategic Initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America Mesenchymal Stem Cells Market, by Region, 2018-2030 (USD Million)
Table 3 North America Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 4 North America Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 5 North America Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 6 North America Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 7 North America Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 8 North America Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 9 U.S. Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 10 U.S. Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 11 U.S. Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 12 U.S. Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 13 U.S. Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 14 U.S. Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 15 Canada Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 16 Canada Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 17 Canada Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 18 Canada Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 19 Canada Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 20 Canada Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 21 Europe Mesenchymal Stem Cells Market, by Region, 2018-2030 (USD Million)
Table 22 Europe Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 23 Europe Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 24 Europe Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 25 Europe Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 26 Europe Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 27 Europe Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 28 Germany Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 29 Germany Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 30 Germany Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 31 Germany Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 32 Germany Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 33 Germany Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 34 UK Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 35 UK Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 36 UK Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 37 UK Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 38 UK Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 39 UK Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 40 France Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 41 France Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 42 France Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 43 France Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 44 France Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 45 France Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 46 Italy Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 47 Italy Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 48 Italy Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 49 Italy Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 50 Italy Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 51 Italy Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 52 Spain Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 53 Spain Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 54 Spain Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 55 Spain Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 56 Spain Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 57 Spain Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 58 Denmark Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 59 Denmark Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 60 Denmark Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 61 Denmark Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 62 Denmark Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 63 Denmark Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 64 Sweden Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 65 Sweden Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 66 Sweden Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 67 Sweden Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 68 Sweden Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 69 Sweden Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 70 Norway Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 71 Norway Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 72 Norway Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 73 Norway Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 74 Norway Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 75 Norway Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 76 Asia-Pacific Mesenchymal Stem Cells Market, by Region, 2018-2030 (USD Million)
Table 77 Asia-Pacific Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 78 Asia-Pacific Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 79 Asia-Pacific Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 80 Asia-Pacific Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 81 Asia-Pacific Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 82 Asia-Pacific Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 83 China Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 84 China Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 85 China Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 86 China Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 87 China Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 88 China Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 89 Japan Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 90 Japan Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 91 Japan Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 92 Japan Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 93 Japan Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 94 Japan Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 95 India Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 96 India Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 97 India Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 98 India Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 99 India Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 100 India Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 101 South Korea Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 102 South Korea Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 103 South Korea Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 104 South Korea Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 105 South Korea Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 106 South Korea Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 107 Australia Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 108 Australia Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 109 Australia Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 110 Australia Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 111 Australia Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 112 Australia Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 113 Thailand Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 114 Thailand Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 115 Thailand Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 116 Thailand Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 117 Thailand Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 118 Thailand Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 119 Latin America Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 120 Latin America Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 121 Latin America Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 122 Latin America Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 123 Latin America Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 124 Latin America Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 125 Brazil Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 126 Brazil Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 127 Brazil Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 128 Brazil Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 129 Brazil Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 130 Brazil Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 131 Mexico Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 132 Mexico Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 133 Mexico Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 134 Mexico Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 135 Mexico Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 136 Mexico Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 137 Argentina Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 138 Argentina Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 139 Argentina Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 140 Argentina Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 141 Argentina Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 142 Argentina Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 143 MEA Mesenchymal Stem Cells Market, by Region, 2018-2030 (USD Million)
Table 144 MEA Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 145 MEA Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 146 MEA Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 147 MEA Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 148 MEA Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 149 MEA Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 150 South Africa Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 151 South Africa Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 152 South Africa Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 153 Saudi Arabia Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 154 Saudi Arabia Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 155 Saudi Arabia Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 156 Saudi Arabia Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 157 Saudi Arabia Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 158 Saudi Arabia Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 159 UAE Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 160 UAE Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 161 UAE Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 162 UAE Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 163 UAE Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 164 UAE Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)
Table 165 Kuwait Mesenchymal Stem Cells Market, by Products & Services, 2018-2030 (USD Million)
Table 166 Kuwait Mesenchymal Stem Cells Market, by Workflow Type, 2018-2030 (USD Million)
Table 167 Kuwait Mesenchymal Stem Cells Market, by Type, 2018-2030 (USD Million)
Table 168 Kuwait Mesenchymal Stem Cells Market, by Source of Isolation, 2018-2030 (USD Million)
Table 169 Kuwait Mesenchymal Stem Cells Market, by Indication, 2018-2030 (USD Million)
Table 170 Kuwait Mesenchymal Stem Cells Market, by Application, 2018-2030 (USD Million)

List of Figures

Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Primary Interviews in North America
Figure 5 Primary Interviews in Europe
Figure 6 Primary Interviews in APAC
Figure 7 Primary Interviews in Latin America
Figure 8 Primary Interviews in MEA
Figure 9 Market Research Approaches
Figure 10 Value-chain-based Sizing & Forecasting
Figure 11 QFD Modeling for Market Share Assessment
Figure 12 Market Formulation & Validation
Figure 13 Mesenchymal Stem Cells Market: Market Outlook
Figure 14 Mesenchymal Stem Cells Competitive Insights
Figure 15 Parent Market Outlook
Figure 16 Related/ancillary Market Outlook
Figure 17 Penetration and Growth Prospect Mapping
Figure 18 Industry Value Chain Analysis
Figure 19 Mesenchymal Stem Cells Market Driver Impact
Figure 20 Mesenchymal Stem Cells Market Restraint Impact
Figure 21 Mesenchymal Stem Cells Market Strategic Initiatives Analysis
Figure 22 Mesenchymal Stem Cells Market: Products & Services Movement Analysis
Figure 23 Mesenchymal Stem Cells Market: Products & Services Outlook and Key Takeaways
Figure 24 Products Market Estimates and Forecast, 2018-2030
Figure 25 Cells & Cell Lines Estimates and Forecast, 2018-2030.
Figure 26 Kits, Media, & Reagents Market Estimates and Forecast, 2018-2030
Figure 27 Others Market Estimates and Forecast, 2018-2030
Figure 28 Services Market Estimates and Forecast, 2018-2030
Figure 29 Mesenchymal Stem Cells Market: Workflow Type Movement Analysis
Figure 30 Mesenchymal Stem Cells Market: Workflow Type Outlook and Key Takeaways
Figure 31 Cell Sourcing & Isolation Market Estimates and Forecasts, 2018-2030
Figure 32 Culture & Cryopreservation Market Estimates and Forecasts, 2018-2030
Figure 33 Differentiation Market Estimates and Forecasts, 2018-2030
Figure 34 Characterization Market Estimates and Forecasts, 2018-2030
Figure 35 Mesenchymal Stem Cells Market: Type Movement Analysis
Figure 36 Mesenchymal Stem Cells Market: Type Outlook and Key Takeaways
Figure 37 Autologous Market Estimates and Forecasts, 2018-2030
Figure 38 Allogenic Market Estimates and Forecasts, 2018-2030
Figure 39 Mesenchymal Stem Cells Market: Source of Isolation Movement Analysis
Figure 40 Mesenchymal Stem Cells Market: Source of Isolation Outlook and Key Takeaways
Figure 41 Bone Marrow Market Estimates and Forecasts, 2018-2030
Figure 42 Cord Blood Market Estimates and Forecasts, 2018-2030
Figure 43 Peripheral Blood Market Estimates and Forecasts, 2018-2030
Figure 44 Fallopian Tube Market Estimates and Forecasts, 2018-2030
Figure 45 Fetal Liver Market Estimates and Forecasts, 2018-2030
Figure 46 Lung Market Estimates and Forecasts, 2018-2030
Figure 47 Adipose Tissues Market Estimates and Forecasts, 2018-2030
Figure 48 Mesenchymal Stem Cells Market: Indication Movement Analysis
Figure 49 Mesenchymal Stem Cells Market: Indication Outlook and Key Takeaways
Figure 50 Bone and Cartilage Repair Market Estimates and Forecasts, 2018-2030
Figure 51 Cardiovascular Diseases Market Estimates and Forecasts, 2018-2030
Figure 52 Inflammatory and Immunological Diseases Market Estimates and Forecasts, 2018-2030
Figure 53 Liver Diseases Market Estimates and Forecasts, 2018-2030
Figure 54 Cancer Market Estimates and Forecasts, 2018-2030
Figure 55 GvHD Market Estimates and Forecasts, 2018-2030
Figure 56 Others Market Estimates and Forecasts, 2018-2030
Figure 57 Mesenchymal Stem Cells Market: Application Movement Analysis
Figure 58 Mesenchymal Stem Cells Market: Application Outlook and Key Takeaways
Figure 59 Disease Modeling Market Estimates and Forecasts, 2018-2030
Figure 60 Drug Development & Discovery Market Estimates and Forecasts, 2018-2030
Figure 61 Stem Cell Banking Market Estimates and Forecasts, 2018-2030
Figure 62 Tissue Engineering Market Estimates and Forecasts, 2018-2030
Figure 63 Toxicology Studies Market Estimates and Forecasts, 2018-2030
Figure 64 Others Market Estimates and Forecasts, 2018-2030
Figure 65 Global Mesenchymal Stem Cells Market: Regional Movement Analysis
Figure 66 Global Mesenchymal Stem Cells Market: Regional Outlook and Key Takeaways
Figure 67 North America Market Estimates and Forecasts, 2018-2030
Figure 68 U.S. Market Estimates and Forecasts, 2018-2030
Figure 69 Canada Market Estimates and Forecasts, 2018-2030
Figure 70 Europe Market Estimates and Forecasts, 2018-2030
Figure 71 UK Market Estimates and Forecasts, 2018-2030
Figure 72 Germany Market Estimates and Forecasts, 2018-2030
Figure 73 France Market Estimates and Forecasts, 2018-2030
Figure 74 Italy Market Estimates and Forecasts, 2018-2030
Figure 75 Spain Market Estimates and Forecasts, 2018-2030
Figure 76 Denmark Market Estimates and Forecasts, 2018-2030
Figure 77 Sweden Market Estimates and Forecasts, 2018-2030
Figure 78 Norway Market Estimates and Forecasts, 2018-2030
Figure 79 Asia-Pacific Market Estimates and Forecasts, 2018-2030
Figure 80 China Market Estimates and Forecasts, 2018-2030
Figure 81 Japan Market Estimates and Forecasts, 2018-2030
Figure 82 India Market Estimates and Forecasts, 2018-2030
Figure 83 Thailand Market Estimates and Forecasts, 2018-2030
Figure 84 South Korea Market Estimates and Forecasts, 2018-2030
Figure 85 Australia Market Estimates and Forecasts, 2018-2030
Figure 86 Latin America Market Estimates and Forecasts, 2018-2030
Figure 87 Brazil Market Estimates and Forecasts, 2018-2030
Figure 88 Mexico Market Estimates and Forecasts, 2018-2030
Figure 89 Argentina Market Estimates and Forecasts, 2018-2030
Figure 90 Middle East and Africa Market Estimates and Forecasts, 2018-2030
Figure 91 South Africa Market Estimates and Forecasts, 2018-2030
Figure 92 Saudi Arabia Market Estimates and Forecasts, 2018-2030
Figure 93 UAE Market Estimates and Forecasts, 2018-2030
Figure 94 Kuwait Market Estimates and Forecasts, 2018-2030
Figure 95 Market Share of Key Market Players - Mesenchymal Stem Cells Market

Companies Mentioned

Thermo Fisher Scientific, Inc.
Cell Applications, Inc.
Cyagen Biosciences
Axol Bioscience Ltd.
STEMCELL Technologies
Celprogen Inc.
Cellcolabs
Stemedica Cell Technologies, Inc.
Merck KGaA
Lonza
PromoCell GmbH

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	120
Published	May 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 3.12 Billion
Forecasted Market Value ( USD ) by 2030	$ 7.27 Billion
Compound Annual Growth Rate	12.9%
Regions Covered	Global
No. of Companies Mentioned	11

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5898EUR$5,950USD£4,896GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6889EUR$6,950USD£5,718GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€8872EUR$8,950USD£7,364GBP

Mesenchymal Stem Cells Market Report Highlights

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Mesenchymal Stem Cells Market by Type, Indication, Source of Isolation, Application - Global Forecast 2025-2030

Mesenchymal Stem Cells Global Market Report 2024

Mesenchymal Stem Cells (MSC) - Global Strategic Business Report

Mesenchymal Stem Cell Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) - Advances & Applications, 2025